@NP	Synergic Effects	1
@NP	EPI-NCSCs and OECs on the Donor Cells Migration	21
@NP	EPI-NCSCs and OECs	21
@NP	the Donor Cells Migration	43
@NP	the Expression of Neurotrophic Factors	70
@NP	the Expression	70
@NP	Neurotrophic Factors	88
@NP	Locomotor Recovery	114
@NP	Contused Spinal Cord	136
@NP	a promising strategy for the repair of spinal cord injury -LRB- SCI -RRB-	292
@NP	a promising strategy	292
@NP	the repair of spinal cord injury -LRB- SCI -RRB-	317
@NP	the repair	317
@NP	spinal cord injury -LRB- SCI -RRB-	331
@NP	spinal cord injury	331
@NP	SCI	351
@NP	the synergic effects of donor cells	361
@NP	the synergic effects	361
@NP	donor cells	385
@NP	recent years	415
@NP	this study	432
@NP	epidermal neural crest stem cells -LRB- EPI-NCSCs -RRB-	444
@NP	epidermal neural crest stem cells	444
@NP	EPI-NCSCs	479
@NP	olfactory ensheathing cells -LRB- OECs -RRB-	494
@NP	olfactory ensheathing cells	494
@NP	OECs	523
@NP	the contused spinal cord of rats separately or jointly at 1 week	552
@NP	spinal cord of rats	565
@NP	spinal cord	565
@NP	rats	580
@NP	1	610
@NP	injury	623
@NP	3 and 9 weeks posttransplantation	634
@NP	3 and 9 weeks	634
@NP	posttransplantation	648
@NP	migration of the donor cells	669
@NP	migration	669
@NP	the donor cells	682
@NP	expression of brain-derived neurotrophic factor -LRB- BDNF -RRB-	699
@NP	expression	699
@NP	brain-derived neurotrophic factor	713
@NP	BDNF	748
@NP	glial cell line-derived neurotrophic factor -LRB- GDNF -RRB-	758
@NP	glial cell	758
@NP	line-derived neurotrophic factor -LRB- GDNF -RRB-	769
@NP	line-derived neurotrophic factor	769
@NP	GDNF	803
@NP	functional recovery of the contused cord	813
@NP	functional recovery	813
@NP	the contused cord	836
@NP	the	836
@NP	cord	849
@NP	techniques	873
@NP	histopathology	887
@NP	quantitative real-time polymerase chain reaction	903
@NP	quantitative real-time polymerase	903
@NP	chain reaction	937
@NP	qPCR	953
@NP	immunohistochemistry	960
@NP	Basso -- Beattie -- Bresnahan -LRB- BBB -RRB- score	985
@NP	Basso -- Beattie -- Bresnahan -LRB- BBB -RRB-	985
@NP	Basso -- Beattie -- Bresnahan	985
@NP	Beattie	991
@NP	BBB	1010
@NP	score	1015
@NP	The results	1022
@NP	themigration and distribution of EPI-NCSCs in vivo	1046
@NP	themigration and distribution	1046
@NP	EPI-NCSCs in vivo	1079
@NP	EPI-NCSCs	1079
@NP	vivo	1092
@NP	OECs at 3 weeks	1114
@NP	OECs	1114
@NP	3 weeks	1122
@NP	transplantation	1136
@NP	they	1157
@NP	9 weeks	1174
@NP	The expression of BDNF and GDNF	1183
@NP	The expression	1183
@NP	BDNF and GDNF	1201
@NP	co-transplantation	1246
@NP	molecular and protein level	1268
@NP	molecular	1268
@NP	protein level	1282
@NP	the expression of both factors in EPI-NCSCs - and OECs-injected group	1306
@NP	the expression	1306
@NP	both factors in EPI-NCSCs - and OECs-injected group	1324
@NP	both factors	1324
@NP	EPI-NCSCs	1340
@NP	OECs-injected group	1355
@NP	coinjected group	1393
@NP	it	1411
@NP	control groups	1433
@NP	the best locomotor recovery of the contused cordwas	1460
@NP	the best locomotor recovery	1460
@NP	the contused cordwas	1491
@NP	co-injected animals	1526
@NP	we	1550
@NP	this	1559
@NP	the first time to study the synergic effects of EPI-NCSCs and OECs	1567
@NP	the synergic effects of EPI-NCSCs and OECs	1591
@NP	the synergic effects	1591
@NP	EPI-NCSCs and OECs	1615
@NP	the data	1639
@NP	donor cells migration	1663
@NP	donor cells	1663
@NP	migration	1675
@NP	expression of neurotrophic factors -LRB- NTFs -RRB-	1686
@NP	expression	1686
@NP	neurotrophic factors -LRB- NTFs -RRB-	1700
@NP	neurotrophic factors	1700
@NP	NTFs	1722
@NP	recovery of motor function	1733
@NP	recovery	1733
@NP	motor function	1745
@NP	EPI-NCSCs and OECs	1779
@NP	Introduction Spinal cord injury -LRB- SCI -RRB-	1816
@NP	Introduction Spinal cord injury	1816
@NP	Introduction	1816
@NP	Spinal cord injury	1829
@NP	SCI	1849
@NP	complex pathophysiological processes	1864
@NP	complete or partial loss of sensation and mobility	1917
@NP	complete or partial loss	1917
@NP	sensation and mobility	1945
@NP	the life qualities of patients	1979
@NP	the life qualities	1979
@NP	patients	2001
@NP	recent years	2014
@NP	many laboratories	2028
@NP	cell transplantation	2065
@NP	a perspective strategy for treating SCI	2089
@NP	a perspective strategy	2089
@NP	SCI	2125
@NP	SCI	2140
@NP	cell transplantation into the lesion site	2145
@NP	cell transplantation	2145
@NP	the lesion site	2171
@NP	permissive substrates	2211
@NP	nerve cell	2248
@NP	apoptosis	2271
@NP	remyelination	2292
@NP	cascade effect	2320
@NP	inflammatory reaction	2338
@NP	Antonic et al. 2013 ; Cui et al. 2013 ; Li et al. 2013	2361
@NP	Antonic et al. 2013 ; Cui et al. 2013 ; Li et al.	2361
@NP	et al. 2013 ; Cui et al. 2013 ; Li et al.	2369
@NP	et al. 2013	2369
@NP	et al.	2369
@NP	2013	2376
@NP	Cui et al. 2013	2382
@NP	Cui	2382
@NP	et al.	2386
@NP	2013	2393
@NP	Li et al.	2399
@NP	Li	2399
@NP	et al.	2402
@NP	2013	2409
@NP	Different cell types	2416
@NP	olfactory ensheathing cells -LRB- OECs -RRB-	2448
@NP	olfactory ensheathing cells	2448
@NP	OECs	2477
@NP	Schwann cells -LRB- SCs -RRB-	2484
@NP	Schwann cells	2484
@NP	SCs	2499
@NP	neural stemcells -LRB- NSCs -RRB-	2505
@NP	neural stemcells	2505
@NP	NSCs	2523
@NP	marrow stroma cells -LRB- MSCs -RRB-	2534
@NP	marrow stroma cells	2534
@NP	MSCs	2555
@NP	donor cells for transplantation	2579
@NP	donor cells	2579
@NP	transplantation	2595
@NP	SCI	2617
@NP	variable degrees	2626
@NP	success	2646
@NP	Hooshmand	2655
@NP	et al. 2009 ; Quertainmont et al. 2012 ; Wang et al. 2012 ; Mayeur et al. 2013	2665
@NP	et al. 2009 ; Quertainmont et al. 2012 ; Wang et al. 2012 ; Mayeur et al.	2665
@NP	et al. 2009	2665
@NP	et al.	2665
@NP	2009	2672
@NP	Quertainmont et al. 2012	2678
@NP	Quertainmont	2678
@NP	et al.	2691
@NP	2012	2698
@NP	Wang et al. 2012	2704
@NP	Wang	2704
@NP	et al.	2709
@NP	2012	2716
@NP	Mayeur et al.	2722
@NP	Mayeur	2722
@NP	et al.	2729
@NP	2013	2736
@NP	Epidermal neural crest stem cells -LRB- EPI-NCSCs -RRB-	2743
@NP	Epidermal neural crest stem cells	2743
@NP	EPI-NCSCs	2778
@NP	the embryonic neural crest	2803
@NP	a strong candidate for cell - based therapy	2834
@NP	a strong candidate	2834
@NP	cell	2857
@NP	therapy	2869
@NP	they	2886
@NP	the advantages of embryonic stemcells and adult stem cells	2899
@NP	the advantages	2899
@NP	embryonic stemcells and adult stem cells	2917
@NP	embryonic stemcells	2917
@NP	adult stem cells	2941
@NP	EPI-NCSCs transplantation	2959
@NP	an attractive strategy	2988
@NP	a significant improvement	3023
@NP	sensory connectivity and touch perception following SCI	3052
@NP	sensory connectivity and touch perception	3052
@NP	SCI	3104
@NP	neurotrophic factors , angiogenic factors and extracellular proteases	3123
@NP	neurotrophic factors	3123
@NP	angiogenic factors	3145
@NP	extracellular proteases	3168
@NP	combination	3202
@NP	the capability	3219
@NP	cell survival	3248
@NP	neovascularization and modulation	3263
@NP	scar formation -LRB- Pandamooz et al. 2013 -RRB-	3300
@NP	scar formation	3300
@NP	Pandamooz et al. 2013	3316
@NP	Pandamooz	3316
@NP	et al. 2013	3326
@NP	et al.	3326
@NP	2013	3333
@NP	the poor migration of grafted EPI-NCSCs in the injured cord	3349
@NP	the poor migration	3349
@NP	grafted EPI-NCSCs in the injured cord	3371
@NP	grafted EPI-NCSCs	3371
@NP	the injured cord	3392
@NP	a major challenge -LRB- Sieber-Blum et al. 2006 -RRB-	3417
@NP	a major challenge	3417
@NP	Sieber-Blum et al. 2006	3436
@NP	Sieber-Blum	3436
@NP	et al. 2006	3448
@NP	et al.	3448
@NP	2006	3455
@NP	OECs	3462
@NP	a central role in the repair of SCI	3472
@NP	a central role	3472
@NP	the repair of SCI	3490
@NP	the repair	3490
@NP	SCI	3504
@NP	their abundant production	3515
@NP	growth-promoting factors and cell adhesion molecules	3544
@NP	OECs	3598
@NP	functional recovery	3633
@NP	increase of the survival number of NSCs and axonal regeneration in vivo	3657
@NP	increase	3657
@NP	the survival number of NSCs and axonal regeneration in vivo	3669
@NP	the survival number of NSCs	3669
@NP	the survival number	3669
@NP	NSCs	3692
@NP	axonal regeneration in vivo	3701
@NP	axonal regeneration	3701
@NP	vivo	3724
@NP	Shukla	3730
@NP	et al. 2009	3737
@NP	et al.	3737
@NP	2009	3744
@NP	OECs	3761
@NP	a source	3770
@NP	trophic factors	3782
@NP	nerve growth factor -LRB- NGF -RRB-	3809
@NP	nerve growth factor	3809
@NP	NGF	3830
@NP	brain-derived neurotrophic factor -LRB- BDNF -RRB-	3836
@NP	brain-derived neurotrophic factor	3836
@NP	BDNF	3871
@NP	glial cell-derived neurotrophic factor -LRB- GDNF -RRB-	3878
@NP	glial cell-derived neurotrophic factor	3878
@NP	GDNF	3918
@NP	ciliary neurotrophic factor -LRB- CNTF -RRB-	3929
@NP	ciliary neurotrophic factor	3929
@NP	CNTF	3958
@NP	They	3965
@NP	their environment	3987
@NP	virtue of these trophic molecules -LRB- Radtke and Kocsis 2012 -RRB-	4008
@NP	virtue	4008
@NP	these trophic molecules -LRB- Radtke and Kocsis 2012 -RRB-	4018
@NP	these trophic molecules	4018
@NP	Radtke and Kocsis 2012	4043
@NP	Radtke	4043
@NP	Kocsis 2012	4054
@NP	migration of OECs in the injured spinal cord	4081
@NP	migration	4081
@NP	OECs in the injured spinal cord	4094
@NP	OECs	4094
@NP	the injured spinal cord	4102
@NP	they	4144
@NP	less astrocyte response in vitro and in vivo	4156
@NP	less astrocyte response	4156
@NP	vivo	4196
@NP	astrocyte	4217
@NP	injection -LRB- Santos-Silva et al. 2007 ; Li et al. 2012 -RRB-	4233
@NP	injection	4233
@NP	Santos-Silva	4244
@NP	et al. 2007 ; Li et al. 2012	4257
@NP	et al. 2007 ; Li et al.	4257
@NP	et al. 2007	4257
@NP	et al.	4257
@NP	2007	4264
@NP	Li et al.	4270
@NP	Li	4270
@NP	et al.	4273
@NP	2012	4280
@NP	it	4297
@NP	combination of two kinds of cells	4317
@NP	combination	4317
@NP	two kinds of cells	4332
@NP	two kinds	4332
@NP	cells	4345
@NP	the synergistic effects	4361
@NP	repair of SCI -LRB- Ban et al. 2011 ; Gerin et al. 2011 -RRB-	4388
@NP	repair	4388
@NP	SCI -LRB- Ban et al. 2011 ; Gerin et al. 2011 -RRB-	4398
@NP	SCI	4398
@NP	Ban	4403
@NP	et al. 2011 ; Gerin et al. 2011	4407
@NP	et al. 2011 ; Gerin et al.	4407
@NP	et al. 2011	4407
@NP	et al.	4407
@NP	2011	4414
@NP	Gerin et al.	4420
@NP	Gerin	4420
@NP	et al.	4426
@NP	2011	4433
@NP	the present study	4443
@NP	EPINCSCs and OECs	4462
@NP	the contused spinal cord separately or jointly at 1 week	4503
@NP	spinal cord	4516
@NP	1	4553
@NP	injury for determining whether OECs promote EPI-NCSCs migration	4566
@NP	injury	4566
@NP	OECs	4597
@NP	EPI-NCSCs migration	4610
@NP	their synergistic effects	4635
@NP	the expression of BDNF and GDNF	4664
@NP	the expression	4664
@NP	BDNF and GDNF	4682
@NP	the recovery	4700
@NP	motor function of a clinically relevant model of the contusive SCI	4716
@NP	motor function	4716
@NP	a clinically relevant model of the contusive SCI	4734
@NP	a clinically relevant model	4734
@NP	the contusive SCI	4765
@NP	Materials and Methods Preparation of EPI-NCSCs EPI-NCSCs	4785
@NP	Materials	4785
@NP	Methods Preparation of EPI-NCSCs EPI-NCSCs	4799
@NP	Methods Preparation	4799
@NP	EPI-NCSCs EPI-NCSCs	4822
@NP	whisker follicles	4861
@NP	adult green fluorescence protein -LRB- GFP -RRB- rat	4882
@NP	GFP	4916
@NP	the previous description	4938
@NP	Sieber-Blum and Hu 2008 ; Zhang et al. 2012	4964
@NP	Sieber-Blum and Hu 2008 ; Zhang et al.	4964
@NP	Sieber-Blum and Hu 2008	4964
@NP	Sieber-Blum	4964
@NP	Hu 2008	4980
@NP	Zhang et al.	4989
@NP	Zhang	4989
@NP	et al.	4995
@NP	2012	5002
@NP	whisker follicles	5017
@NP	adult GFP transgenic rats	5055
@NP	adult GFP	5055
@NP	transgenic rats	5065
@NP	Tissue	5082
@NP	cavernous sinus and ring sinus	5160
@NP	The bulges	5192
@NP	the capsule	5222
@NP	collagen-coated culture plates	5250
@NP	they	5287
@NP	the substratum	5303
@NP	30 min	5325
@NP	the culture medium	5338
@NP	85 %	5370
@NP	Dulbecco ' sModified Eagle ' sMedium -LRB- DMEM -RRB- / F12 , 10 %	5373
@NP	Dulbecco ' sModified Eagle ' sMedium -LRB- DMEM -RRB-	5373
@NP	Dulbecco ' sModified Eagle ' sMedium	5373
@NP	Dulbecco '	5373
@NP	Eagle '	5392
@NP	DMEM	5406
@NP	F12 , 10 %	5412
@NP	F12	5412
@NP	10 %	5417
@NP	fetal calf serum	5421
@NP	2 % B27 -LRB- all from Gibco , Grand Island , NY , USA -RRB-	5439
@NP	2 % B27	5439
@NP	all from Gibco	5448
@NP	all	5448
@NP	Gibco	5457
@NP	Grand Island , NY , USA	5464
@NP	Grand Island	5464
@NP	NY , USA	5478
@NP	10 ng/ml of basic fibroblast growth factor -LRB- bFGF , Sigma-Aldrich , St.	5492
@NP	10 ng/ml	5492
@NP	basic fibroblast growth factor -LRB- bFGF , Sigma-Aldrich , St.	5504
@NP	basic fibroblast growth factor	5504
@NP	bFGF	5536
@NP	Sigma-Aldrich , St.	5542
@NP	Louis , MO , USA -RRB-	5561
@NP	Louis	5561
@NP	MO	5568
@NP	USA	5572
@NP	the third day	5591
@NP	cells	5606
@NP	the bulge explants	5637
@NP	the culture substratum	5661
@NP	the bulges	5697
@NP	the adhering cells	5725
@NP	trypsin -LRB- Gibco , Grand Island , NY , USA -RRB- treatment	5756
@NP	trypsin -LRB- Gibco , Grand Island , NY , USA -RRB-	5756
@NP	trypsin	5756
@NP	Gibco	5765
@NP	Grand Island	5772
@NP	NY , USA	5786
@NP	treatment	5795
@NP	It	5835
@NP	these cells	5869
@NP	a pure population	5892
@NP	EPI-NCSCs	5913
@NP	the immunohistochemistry staining	5936
@NP	nestin	5973
@NP	SOX10	5981
@NP	β-III tubulin antibody	5992
@NP	all from Gibco	6016
@NP	all	6016
@NP	Gibco	6025
@NP	Grand Island , NY , USA	6032
@NP	Grand Island	6032
@NP	NY , USA	6046
@NP	The suspension	6056
@NP	the concentration of 1.0 × 105/ul for transplantation	6101
@NP	the concentration	6101
@NP	1.0 × 105/ul for transplantation	6122
@NP	1.0 × 105/ul	6122
@NP	transplantation	6137
@NP	Preparation of OECs OECs	6154
@NP	Preparation	6154
@NP	OECs OECs	6169
@NP	the olfactory bulbs	6199
@NP	adult GFP rats	6222
@NP	Sasaki	6262
@NP	et al. 2004 ; Li et al. 2012	6269
@NP	et al. 2004 ; Li et al.	6269
@NP	et al. 2004	6269
@NP	et al.	6269
@NP	2004	6276
@NP	Li et al.	6282
@NP	Li	6282
@NP	et al.	6285
@NP	2012	6292
@NP	the olfactory bulbs removed from adult GFP rats	6308
@NP	the olfactory bulbs	6308
@NP	adult GFP rats	6341
@NP	meninges and white matter	6379
@NP	meninges	6379
@NP	white matter	6392
@NP	scalpel blades	6418
@NP	25 min in trypsin	6452
@NP	25 min	6452
@NP	trypsin	6462
@NP	37 °C within the CO2 incubator	6473
@NP	37 °C	6473
@NP	the CO2 incubator	6486
@NP	tissue	6510
@NP	a very gentle mechanical trituration	6538
@NP	a culture flask	6598
@NP	DMEM/F12 medium	6617
@NP	10 % fetal calf serum	6638
@NP	10 ng/ml bFGF	6661
@NP	2 uM Forskolin -LRB- Sigma-Aldrich , St.	6680
@NP	2 uM Forskolin	6680
@NP	Sigma-Aldrich	6696
@NP	St.	6711
@NP	Louis , MO , USA -RRB- .	6715
@NP	Louis	6715
@NP	USA	6726
@NP	5 -- 7 days	6738
@NP	5	6738
@NP	7 days	6740
@NP	antibody staining	6748
@NP	at least 95 % of donor cells	6791
@NP	at least 95 %	6791
@NP	donor cells	6808
@NP	both P75 -LRB- 1:200 dilution -RRB-	6825
@NP	both P75	6825
@NP	1:200 dilution	6835
@NP	S-100 -LRB- 1:500 dilution ; all from Abcam , Cambridge , MA , USA -RRB-	6855
@NP	S-100	6855
@NP	1:500 dilution ; all from Abcam , Cambridge , MA , USA	6862
@NP	1:500 dilution	6862
@NP	all from Abcam , Cambridge , MA , USA	6878
@NP	all from Abcam , Cambridge , MA ,	6878
@NP	all	6878
@NP	Abcam , Cambridge , MA ,	6887
@NP	USA	6909
@NP	The suspension	6924
@NP	the concentration of 1.0 × 105/ul for transplantation	6969
@NP	the concentration	6969
@NP	1.0 × 105/ul for transplantation	6990
@NP	1.0 × 105/ul	6990
@NP	transplantation	7005
@NP	Spinal Cord	7022
@NP	Injury and Animal Groups Adult male Sprague Dawley -LRB- SD -RRB- rats	7034
@NP	Injury and Animal Groups	7034
@NP	Adult male Sprague Dawley -LRB- SD -RRB- rats	7059
@NP	SD	7086
@NP	200 -- 250 g	7096
@NP	200	7096
@NP	250 g	7100
@NP	the Third Military Medical University -LRB- TMMU -RRB- guidelines	7132
@NP	TMMU	7171
@NP	surgical procedures and postop care	7193
@NP	surgical procedures	7193
@NP	postop care	7217
@NP	accordance	7247
@NP	protocols approved by TMMU Institutional Animal Care and Use Committee	7263
@NP	protocols	7263
@NP	TMMU Institutional Animal Care and Use Committee	7285
@NP	Rats	7335
@NP	a single intraperitoneal injection of 1 % pentobarbital -LRB- 30 mg/kg -RRB-	7363
@NP	a single intraperitoneal injection	7363
@NP	1 % pentobarbital -LRB- 30 mg/kg -RRB-	7401
@NP	1 % pentobarbital	7401
@NP	30 mg/kg	7420
@NP	a sterile laminectomy	7435
@NP	vertebral levels T10	7474
@NP	The spinal cords	7496
@NP	an NYU II impactor with a dropping weight	7533
@NP	an NYU II impactor	7533
@NP	a dropping weight	7557
@NP	10.0 g from 25 mm above the exposed cord	7575
@NP	10.0 g	7575
@NP	25 mm above the exposed cord	7587
@NP	25 mm	7587
@NP	the exposed cord	7599
@NP	injury	7623
@NP	the muscle and skin	7631
@NP	layers	7666
@NP	The procedure	7674
@NP	hind limb paralysis	7700
@NP	all animals	7723
@NP	some of them	7740
@NP	some	7740
@NP	them	7748
@NP	hematuria and urinary retention	7762
@NP	hematuria	7762
@NP	urinary retention	7776
@NP	the infections	7806
@NP	Bicillin -LRB- 60,000 U/kg , i.m. -RRB-	7822
@NP	Bicillin	7822
@NP	60,000 U/kg , i.m.	7832
@NP	60,000 U/kg	7832
@NP	i.m.	7845
@NP	7 days with bladder expression	7871
@NP	7 days	7871
@NP	bladder expression	7883
@NP	twice a day	7902
@NP	recovery of the urinate function	7920
@NP	recovery	7920
@NP	the urinate function	7932
@NP	The contused rats	7954
@NP	five groups -LRB- n = 20/group -RRB-	7999
@NP	five groups	7999
@NP	n = 20/group	8012
@NP	n	8012
@NP	= 20/group	8013
@NP	Group A	8025
@NP	the blank control	8037
@NP	transplantation	8063
@NP	Group B	8080
@NP	6 ul DMEM/F12	8104
@NP	Groups C , D , and E	8119
@NP	Groups	8119
@NP	C , D , and E	8126
@NP	6 ul suspension of EPI-NCSCs , OECs , and mixed EPI-NCSCs-OECs	8161
@NP	6 ul suspension	8161
@NP	EPI-NCSCs , OECs , and mixed EPI-NCSCs-OECs	8180
@NP	EPI-NCSCs	8180
@NP	OECs	8191
@NP	mixed EPI-NCSCs-OECs	8201
@NP	day 7 after injury	8240
@NP	day 7	8240
@NP	injury	8252
@NP	Cell Transplantation The transplantation	8260
@NP	Cell Transplantation	8260
@NP	The transplantation	8281
@NP	day 7	8318
@NP	spinal cord injury	8330
@NP	The rats	8350
@NP	the laminectomy site	8396
@NP	Two microliters of cell suspension	8433
@NP	Two microliters	8433
@NP	cell suspension	8452
@NP	the midline	8488
@NP	the	8503
@NP	cord	8516
@NP	a depth	8524
@NP	0.8 mm at the epicenter of the lesion , and at 1 mm rostral and caudal	8535
@NP	0.8 mm	8535
@NP	the epicenter of the lesion	8545
@NP	the epicenter	8545
@NP	the lesion	8562
@NP	1 mm rostral and caudal	8581
@NP	1 mm rostral	8581
@NP	caudal	8598
@NP	the epicenter	8608
@NP	a total of 6 μl of cell suspension	8623
@NP	a total	8623
@NP	6 μl of cell suspension	8634
@NP	6 μl	8634
@NP	cell suspension	8642
@NP	The cell injections	8668
@NP	a 5-ul Hamilton syringe , which remained in place for 5 min after each injection	8709
@NP	a 5-ul Hamilton syringe	8709
@NP	place for 5 min	8752
@NP	place	8752
@NP	5 min	8762
@NP	each injection	8774
@NP	The control animals	8790
@NP	identical volumes of DMEM/F12	8827
@NP	identical volumes	8827
@NP	DMEM/F12	8848
@NP	the same sites	8860
@NP	the injection	8882
@NP	the muscle and skin	8897
@NP	interrupted sutures	8934
@NP	CyclosporinA -LRB- 10 mg/kg , i.m. -RRB-	8955
@NP	CyclosporinA	8955
@NP	10 mg/kg , i.m.	8969
@NP	10 mg/kg	8969
@NP	i.m.	8979
@NP	euthanasia	9007
@NP	Immunofluorescent Staining and Measurement of the Donor	9019
@NP	Immunofluorescent Staining and Measurement	9019
@NP	the Donor	9065
@NP	Cells	9075
@NP	Three and 9 weeks posttransplantation , the rat	9081
@NP	Three and 9 weeks	9081
@NP	posttransplantation , the rat	9099
@NP	posttransplantation	9099
@NP	the rat	9120
@NP	spinal cord	9128
@NP	4 % paraformaldehyde	9168
@NP	the same fixative	9206
@NP	24 h , then transferred to 20 % sucrose for 48 h.	9228
@NP	24 h	9228
@NP	20 % sucrose for 48 h.	9254
@NP	20 % sucrose	9254
@NP	48 h.	9271
@NP	Segments of the spinal cord -LRB- between the T9 and T11 -RRB-	9277
@NP	Segments	9277
@NP	the spinal cord -LRB- between the T9 and T11 -RRB-	9289
@NP	the spinal cord	9289
@NP	the T9 and T11	9314
@NP	optimal cutting temperature compound -LRB- OCT , Boster , Wuhan , China -RRB-	9347
@NP	optimal cutting temperature compound	9347
@NP	OCT	9385
@NP	Boster	9390
@NP	Wuhan , China	9398
@NP	a cryostat -LRB- LEICA CM-1900 , GE -RRB-	9438
@NP	a cryostat	9438
@NP	LEICA CM-1900	9450
@NP	GE	9465
@NP	serial 15-μm-thick sagittal frozen sections	9474
@NP	serial	9474
@NP	15-μm-thick sagittal frozen sections	9481
@NP	The frozen slides	9519
@NP	air dried at room temperature for 10 min and washed with PBS for 10 min	9542
@NP	air	9542
@NP	room temperature	9555
@NP	10 min	9576
@NP	PBS for 10 min	9599
@NP	PBS	9599
@NP	10 min	9607
@NP	they	9620
@NP	3 % bovine serum albumin -LRB- BSA -RRB-	9643
@NP	3 % bovine serum albumin	9643
@NP	3 %	9643
@NP	BSA	9669
@NP	0.3 % Triton X-100 for 1 h	9685
@NP	0.3 % Triton X-100	9685
@NP	1 h	9707
@NP	room temperature	9714
@NP	anti-S-100 antibody -LRB- 1:500 dilution -RRB-	9748
@NP	anti-S-100 antibody	9748
@NP	1:500 dilution	9769
@NP	anti-β-III tubulin antibody -LRB- 1:1,000 dilution -RRB-	9786
@NP	anti-β-III tubulin antibody	9786
@NP	1:1,000 dilution	9815
@NP	anti-nestin polyclonal antibody	9838
@NP	1:1,000 dilution ; all from Gibco	9871
@NP	1:1,000 dilution	9871
@NP	all from Gibco	9889
@NP	all	9889
@NP	Gibco	9898
@NP	Grand Island , NY , USA	9905
@NP	Grand Island	9905
@NP	NY , USA	9919
@NP	overnight	9928
@NP	4 °C	9941
@NP	The slides	9947
@NP	PBS	9973
@NP	three times	9977
@NP	fluorescein-conjugate affinipure -LRB- FITC -RRB-	10008
@NP	fluorescein-conjugate affinipure	10008
@NP	FITC	10042
@NP	goat anti-rabbit IgG -LRB- 1:100 dilution -RRB- for 2 h at 37 °C	10048
@NP	goat anti-rabbit IgG -LRB- 1:100 dilution -RRB-	10048
@NP	goat anti-rabbit IgG	10048
@NP	1:100 dilution	10070
@NP	2 h at 37 °C	10090
@NP	2 h	10090
@NP	37 °C	10097
@NP	repeat washing with PBS	10110
@NP	repeat	10110
@NP	PBS	10130
@NP	the slides	10135
@NP	Hoechst 33342 -LRB- 1:100 dilution ; all from Boster , Wuhan , China -RRB-	10166
@NP	Hoechst 33342	10166
@NP	1:100 dilution ; all from Boster	10181
@NP	1:100 dilution	10181
@NP	all from Boster	10197
@NP	all	10197
@NP	Boster	10206
@NP	Wuhan , China	10214
@NP	Wuhan	10214
@NP	China	10221
@NP	30 min	10232
@NP	37 °C	10242
@NP	Gel / Mount aqueous mounting media	10270
@NP	Mount	10275
@NP	media	10298
@NP	The sections	10305
@NP	fluorescence microscope -LRB- Olympus BX50 , JPN -RRB-	10338
@NP	fluorescence microscope	10338
@NP	Olympus BX50	10363
@NP	JPN	10377
@NP	the distribution area	10397
@NP	the migration distances	10420
@NP	the number of fluorescence cells	10448
@NP	the number	10448
@NP	fluorescence cells	10462
@NP	images	10482
@NP	× 20	10515
@NP	Olympus BX50 light microscope	10525
@NP	every fifth section	10560
@NP	a total of five sections from each animal	10585
@NP	a total	10585
@NP	five sections from each animal	10596
@NP	five sections	10596
@NP	each animal	10615
@NP	Adobe Photoshop 10.0	10645
@NP	Spot 345 software	10682
@NP	Quantitative Real-Time Polymerase Chain Reaction	10701
@NP	the mRNA sequence	10763
@NP	GDNF and BDNF -LRB- http://www.ncbi.nlm.nih.gov/genbank -RRB-	10784
@NP	GDNF and BDNF	10784
@NP	http://www.ncbi.nlm.nih.gov/genbank	10799
@NP	the primers -LRB- Table 1 -RRB-	10837
@NP	the primers	10837
@NP	Table 1	10850
@NP	the GeneTool software -LRB- Biotools , USA -RRB-	10876
@NP	the GeneTool software	10876
@NP	Biotools	10899
@NP	USA	10909
@NP	The spinal cord segments -LRB- about 10 mm -RRB- centered on the injury site	10915
@NP	The spinal cord segments -LRB- about 10 mm -RRB-	10915
@NP	The spinal cord segments	10915
@NP	10 mm	10947
@NP	the injury site	10966
@NP	3 and 9 weeks after SCI -LRB- n = 5/group/time point -RRB-	10999
@NP	3 and 9 weeks	10999
@NP	SCI -LRB- n = 5/group/time point -RRB-	11019
@NP	SCI	11019
@NP	n = 5/group/time point	11024
@NP	n	11024
@NP	= 5/group/time point	11025
@NP	They	11047
@NP	TRIzol reagent and DNaseI -LRB- all from Invitrogen , Carlsbad , CA , USA -RRB-	11072
@NP	TRIzol reagent and DNaseI	11072
@NP	all from Invitrogen , Carlsbad , CA ,	11099
@NP	all	11099
@NP	Invitrogen , Carlsbad , CA ,	11108
@NP	USA	11134
@NP	First strand complementary DNA -LRB- cDNA -RRB-	11140
@NP	First strand complementary DNA	11140
@NP	cDNA	11172
@NP	the Rever Tre Ace-a-reverse transcription kit -LRB- Toyobo , JPN -RRB-	11200
@NP	the Rever Tre Ace-a-reverse transcription kit	11200
@NP	Toyobo	11247
@NP	JPN	11255
@NP	manufacturer 's instructions	11273
@NP	manufacturer 's	11273
@NP	quantitative PCR -LRB- qPCR -RRB-	11306
@NP	quantitative PCR	11306
@NP	qPCR	11324
@NP	20 μl reactions	11331
@NP	10 μl	11360
@NP	2 × SYBR Green , 2 μl cDNA template , and 0.5 μl RT-qPCR Primer Set were used	11366
@NP	2 × SYBR Green	11366
@NP	2 ×	11366
@NP	SYBR Green	11369
@NP	2 μl cDNA template	11381
@NP	0.5 μl RT-qPCR Primer Set were used	11405
@NP	0.5 μl RT-qPCR Primer	11405
@NP	Thermo cycling conditions	11442
@NP	94 °C for 5 min	11485
@NP	94 °C	11485
@NP	5 min	11495
@NP	30 cycles of 94 °C for 30 s	11502
@NP	30 cycles	11502
@NP	94 °C for 30 s	11515
@NP	94 °C	11515
@NP	30 s	11525
@NP	55 °C for 30 s	11531
@NP	55 °C	11531
@NP	30 s	11541
@NP	72 °C for 30 s	11547
@NP	72 °C	11547
@NP	30 s	11557
@NP	72 °C for 10 min	11567
@NP	72 °C	11567
@NP	10 min	11577
@NP	curve analysis	11593
@NP	a single amplification peak	11615
@NP	each reaction	11647
@NP	Ct values for targets	11662
@NP	Ct values	11662
@NP	targets	11676
@NP	relative expression	11702
@NP	the average of housekeeping genes -LRB- β-actin -RRB-	11734
@NP	the average	11734
@NP	housekeeping genes -LRB- β-actin -RRB-	11749
@NP	housekeeping genes	11749
@NP	β-actin	11769
@NP	Immunohistochemical Staining of BDNF and GDNF The frozen slides were air	11779
@NP	Immunohistochemical Staining	11779
@NP	BDNF and GDNF	11811
@NP	The frozen slides	11825
@NP	air	11848
@NP	room temperature	11861
@NP	10 min	11882
@NP	PBS for 10 min	11905
@NP	PBS	11905
@NP	10 min	11913
@NP	n = 5/group	11921
@NP	n	11921
@NP	= 5/group	11922
@NP	time point	11932
@NP	time	11932
@NP	point	11937
@NP	The sections	11945
@NP	0.3 % Triton X-100 / 10 %	11994
@NP	0.3 % Triton X-100	11994
@NP	10 %	12013
@NP	normal goat serum in 0.01 M PBS for 30 min	12018
@NP	normal goat serum	12018
@NP	0.01 M PBS for 30 min	12039
@NP	0.01 M PBS	12039
@NP	30 min	12054
@NP	polyclonal rabbit antibodies	12082
@NP	1:500 dilution	12122
@NP	1:500 dilution	12153
@NP	4 °C	12182
@NP	The sections	12188
@NP	secondary	12221
@NP	goat anti-rabbit IgG antibody	12244
@NP	goat	12244
@NP	anti-rabbit IgG antibody	12249
@NP	1:1,000 dilution ; Abcam , Cambridge , MA , USA	12275
@NP	1:1,000 dilution	12275
@NP	Abcam , Cambridge , MA , USA	12293
@NP	1 h at room temperature	12324
@NP	1 h	12324
@NP	room temperature	12331
@NP	an avidin -- biotin -- peroxidase complex	12361
@NP	avidin -- biotin --	12364
@NP	avidin	12364
@NP	biotin	12371
@NP	ABC kit , Thermo Fisher Scientific , Rockford , IL , USA	12398
@NP	ABC kit	12398
@NP	Thermo Fisher Scientific	12407
@NP	Rockford	12433
@NP	IL	12443
@NP	USA	12447
@NP	incubation	12459
@NP	5 min with 0.02 % DAB -LRB- Boster , Wuhan , China -RRB- and 0.003 % H2O2	12474
@NP	5 min with 0.02 % DAB -LRB- Boster , Wuhan , China -RRB-	12474
@NP	5 min	12474
@NP	0.02 % DAB -LRB- Boster , Wuhan , China -RRB-	12485
@NP	0.02 % DAB	12485
@NP	Boster	12497
@NP	Wuhan	12505
@NP	China	12512
@NP	0.003 % H2O2	12523
@NP	0.003 %	12523
@NP	H2O2	12531
@NP	the sections	12537
@NP	hematoxylin	12575
@NP	Primary antibody omission controls	12588
@NP	order	12636
@NP	the specificity of the immunohistochemical labeling	12653
@NP	the specificity	12653
@NP	the immunohistochemical labeling	12672
@NP	The sections	12706
@NP	light microscope	12739
@NP	digital images	12762
@NP	× 40	12800
@NP	every fifth section in total of five sections	12809
@NP	every fifth section	12809
@NP	total of five sections	12832
@NP	total	12832
@NP	five sections	12841
@NP	each animal	12860
@NP	The positive area of BDNF and GDNF	12873
@NP	The positive area	12873
@NP	BDNF and GDNF	12894
@NP	Spot 345 software	12926
@NP	that of the blank control group	12962
@NP	that	12962
@NP	the blank control group	12970
@NP	The percentage of the positive area in each group to blank control group	12995
@NP	The percentage	12995
@NP	the positive area in each group to blank control group	13013
@NP	the positive area	13013
@NP	each group to blank control group	13034
@NP	each group	13034
@NP	blank control group	13048
@NP	Assessment of Locomotor Behavior The locomotor behavior of each rat	13084
@NP	Assessment	13084
@NP	Locomotor Behavior The locomotor behavior of each rat	13098
@NP	Locomotor Behavior The locomotor behavior	13098
@NP	each rat	13143
@NP	9 weeks	13178
@NP	transplantation	13192
@NP	Basso -- Beattie -- Bresnahan -LRB- BBB -RRB- hindlimb	13218
@NP	Basso -- Beattie -- Bresnahan -LRB- BBB -RRB-	13218
@NP	Basso -- Beattie -- Bresnahan	13218
@NP	Beattie	13225
@NP	BBB	13244
@NP	n = 10/group	13282
@NP	n	13282
@NP	= 10/group	13283
@NP	Basso	13295
@NP	et al. 1995	13301
@NP	et al.	13301
@NP	1995	13308
@NP	The BBB rating scale	13315
@NP	a 21-point system	13339
@NP	operationally defined behavioral features	13366
@NP	the recovery progression	13420
@NP	complete paralysis to normal locomotion	13450
@NP	complete paralysis	13450
@NP	normal locomotion	13472
@NP	The rating scale	13491
@NP	0 to 21	13520
@NP	score 0	13538
@NP	complete hindlimb paralysis	13556
@NP	score 21	13591
@NP	completely normal locomotor function	13608
@NP	Scores of 1	13646
@NP	Scores	13646
@NP	1	13656
@NP	20	13658
@NP	an animal 's altered ability	13670
@NP	an animal 's	13670
@NP	the hindlimb joints	13706
@NP	weight	13735
@NP	forelimb and hindlimb movement	13761
@NP	Statistical Analysis All values	13793
@NP	Statistical Analysis	13793
@NP	All values	13814
@NP	mean ± standard deviation -LRB- SD -RRB-	13842
@NP	mean ± standard deviation	13842
@NP	SD	13867
@NP	Differences between groups	13872
@NP	Differences	13872
@NP	groups	13892
@NP	statistical significance	13917
@NP	one-way factorial analysis of variance -LRB- ANOVA -RRB-	13948
@NP	one-way factorial analysis	13948
@NP	variance -LRB- ANOVA -RRB-	13978
@NP	variance	13978
@NP	ANOVA	13988
@NP	A p	13996
@NP	0.05 denoted the presence of a significant difference	14007
@NP	0.05	14007
@NP	the presence of a significant difference	14020
@NP	the presence	14020
@NP	a significant difference	14036
@NP	The above tests	14062
@NP	SPSS software version	14099
@NP	11.0 -LRB- SPSS Inc. , Chicago , IL , USA -RRB-	14121
@NP	11.0	14121
@NP	SPSS Inc. , Chicago , IL , USA	14127
@NP	SPSS Inc.	14127
@NP	Chicago	14138
@NP	IL	14147
@NP	USA	14151
@NP	Results	14158
@NP	Table	14166
@NP	1 Primers sets	14172
@NP	qPCR Fig. 1 At 3 weeks	14191
@NP	qPCR Fig.	14191
@NP	1 At 3 weeks	14202
@NP	posttransplantation , migration and distribution of EPINCSCs	14215
@NP	posttransplantation , migration and distribution	14215
@NP	EPINCSCs	14266
@NP	OECs in the	14279
@NP	OECs	14279
@NP	the	14287
@NP	cord on the longitudinal frozen sections	14300
@NP	cord	14300
@NP	the longitudinal frozen sections	14308
@NP	a EPI-NCSCs group .	14342
@NP	b OECs group .	14361
@NP	b OECs	14361
@NP	group	14368
@NP	c co-transplantation group .	14375
@NP	c	14375
@NP	co-transplantation group	14377
@NP	A1 -- C3 were higher magnification of boxed area in a --	14403
@NP	A1	14403
@NP	C3	14406
@NP	higher magnification of boxed area	14414
@NP	higher magnification	14414
@NP	boxed area	14438
@NP	A1 -- C1 showed GFP + graft cells .	14457
@NP	A1	14457
@NP	C1	14460
@NP	GFP + graft cells	14470
@NP	GFP	14470
@NP	graft cells	14475
@NP	A2 -- C2 indicated nuclei stained by Hoechst 33342 .	14488
@NP	A2	14488
@NP	C2	14491
@NP	nuclei stained by Hoechst 33342	14504
@NP	nuclei	14504
@NP	Hoechst 33342	14522
@NP	A3 -- C3 were merged pictures of GFP + and Hoechst 33342 + .	14537
@NP	A3	14537
@NP	C3	14541
@NP	pictures of GFP	14556
@NP	pictures	14556
@NP	GFP	14568
@NP	+	14571
@NP	Hoechst 33342	14577
@NP	+	14590
@NP	d Semiquantification	14593
@NP	distribution area , migration distance , and number	14617
@NP	distribution area	14617
@NP	migration distance	14636
@NP	number	14660
@NP	graft cells	14670
@NP	Scale	14683
@NP	bars	14689
@NP	a -- c = 200 μm , A1 -- C3	14694
@NP	c = 200 μm , A1	14696
@NP	c =	14696
@NP	200 μm	14698
@NP	A1	14706
@NP	50 μm Fig.	14712
@NP	2 Immunofluorescence staining	14724
@NP	differences	14762
@NP	expression of β-III tubulin , nestin and S-100	14777
@NP	expression	14777
@NP	β-III tubulin , nestin and S-100	14791
@NP	β-III tubulin	14791
@NP	nestin	14806
@NP	S-100	14817
@NP	3 weeks post-co-transplantation in the injured spinal cord	14826
@NP	3 weeks post-co-transplantation	14826
@NP	the injured spinal cord	14861
@NP	n = 3/group	14886
@NP	n	14886
@NP	= 3/group	14887
@NP	Arrows	14898
@NP	areas of high positive expression	14914
@NP	areas	14914
@NP	high positive expression	14923
@NP	Scale bars	14949
@NP	100 μm Fig.	14960
@NP	3 Comparison of BDNF and GDNF expression among the different treatment groups	14973
@NP	3 Comparison	14973
@NP	BDNF and GDNF expression among the different treatment groups	14989
@NP	BDNF and GDNF expression	14989
@NP	the different treatment groups	15020
@NP	the qPCR analysis	15067
@NP	3 and 9 weeks after transplantation	15088
@NP	3 and 9 weeks	15088
@NP	transplantation	15108
@NP	p <	15126
@NP	p	15126
@NP	<	15127
@NP	0.05 Fig.	15128
@NP	4 Immunohistochemical staining of BDNF and GDNF	15139
@NP	4 Immunohistochemical staining	15139
@NP	BDNF and GDNF	15173
@NP	3 and 9 weeks after transplantation	15190
@NP	3 and 9 weeks	15190
@NP	transplantation	15210
@NP	-LRB- Column A -RRB- BDNF	15227
@NP	Column A	15228
@NP	3 weeks	15246
@NP	-LRB- Column B -RRB- BDNF	15255
@NP	Column B	15256
@NP	9 weeks	15274
@NP	-LRB- Column C -RRB- GDNF	15283
@NP	Column C	15284
@NP	3 weeks	15302
@NP	-LRB- Column D -RRB- GDNF	15311
@NP	Column D	15312
@NP	9 weeks	15330
@NP	A1	15340
@NP	D1 -RRB- the blank control	15343
@NP	D1	15343
@NP	the blank control	15347
@NP	-LRB- A2 -- D2 -RRB-	15366
@NP	A2 -- D2	15367
@NP	A2	15367
@NP	D2	15370
@NP	-LRB- A3 -- D3 -RRB-	15384
@NP	A3 -- D3	15385
@NP	A3	15385
@NP	D3	15388
@NP	-LRB- A4 -- D4 -RRB-	15404
@NP	A4 -- D4	15405
@NP	A4	15405
@NP	D4	15408
@NP	A5	15419
@NP	D5 -RRB- the co-transplantation	15422
@NP	D5	15422
@NP	the co-transplantation	15426
@NP	-LRB- E -RRB- Semiquantification of BDNF .	15450
@NP	-LRB- E -RRB-	15450
@NP	Semiquantification of BDNF	15454
@NP	Semiquantification	15454
@NP	BDNF	15476
@NP	-LRB- F -RRB- Semi-quantification of GDNF .	15482
@NP	-LRB- F -RRB-	15482
@NP	Semi-quantification of GDNF	15486
@NP	Semi-quantification	15486
@NP	GDNF	15509
@NP	Scale bars	15515
@NP	100 μm Survival	15527
@NP	Migration	15545
@NP	Distribution	15560
@NP	OECs and EPI-NCSCs	15576
@NP	Representative longitudinal sections	15595
@NP	the survival , migration , and distribution of grafted GFP	15639
@NP	the survival , migration , and distribution	15639
@NP	grafted GFP	15684
@NP	cells in the contused spinal cord -LRB- Fig. 1 -RRB-	15697
@NP	cells	15697
@NP	the contused spinal cord -LRB- Fig. 1 -RRB-	15706
@NP	the	15706
@NP	spinal cord -LRB- Fig. 1 -RRB-	15719
@NP	spinal cord	15719
@NP	Fig. 1	15732
@NP	3 weeks after transplantation	15744
@NP	3 weeks	15744
@NP	transplantation	15758
@NP	the green donor cells	15775
@NP	masses at injection site	15809
@NP	masses	15809
@NP	injection site	15819
@NP	EPI-NCSCsinjected group	15837
@NP	migration	15870
@NP	the boundary of graft EPI-NCSCs	15885
@NP	the boundary	15885
@NP	graft EPI-NCSCs	15901
@NP	the surrounding tissue -LRB- Fig. 1a -RRB-	15932
@NP	the surrounding tissue	15932
@NP	Fig. 1a	15956
@NP	OECs-injected group	15970
@NP	the donor cells	15991
@NP	the host tissue	16045
@NP	Fig. 1b	16086
@NP	co-injected group	16100
@NP	the mixed donor cells	16119
@NP	injection site	16155
@NP	the longitudinal axis of the host cord	16176
@NP	the longitudinal axis	16176
@NP	the host cord	16201
@NP	cell beam between the injection sites	16226
@NP	cell beam	16226
@NP	the injection sites	16244
@NP	the injured area -LRB- Fig. 1c -RRB-	16277
@NP	the injured area	16277
@NP	Fig. 1c	16295
@NP	Semi-quantification data	16305
@NP	3 weeks	16345
@NP	the distribution area	16354
@NP	0.342 ±	16380
@NP	0.057 mm2 with the migration distance of 0.399	16386
@NP	0.057 mm2	16386
@NP	the migration distance of 0.399	16401
@NP	the migration distance	16401
@NP	0.399	16427
@NP	± 0.071 mm	16432
@NP	the EPI-NCSCs group	16445
@NP	0.626 ± 0.124 mm2 and 1.710 ± 0.223 mm	16505
@NP	0.626 ± 0.124 mm2	16505
@NP	0.626 ±	16505
@NP	0.124 mm2	16511
@NP	1.710 ± 0.223 mm	16525
@NP	1.710 ±	16525
@NP	0.223 mm	16531
@NP	the OECs group and 0.636 ± 0.182 mm2 and 1.816 ± 0.563 mm	16543
@NP	the OECs group	16543
@NP	0.636 ± 0.182 mm2 and 1.816 ± 0.563 mm	16562
@NP	0.636 ± 0.182 mm2	16562
@NP	0.636 ±	16562
@NP	0.182 mm2	16569
@NP	1.816 ± 0.563 mm	16583
@NP	1.816 ±	16583
@NP	0.563 mm	16589
@NP	the co-transplantation group	16601
@NP	p < 0.05	16631
@NP	p	16631
@NP	< 0.05	16632
@NP	<	16632
@NP	0.05	16633
@NP	9 weeks	16643
@NP	the number of survival green fluorescence cells	16658
@NP	the number	16658
@NP	survival green fluorescence cells	16672
@NP	each group	16733
@NP	no survival green fluorescence cells	16750
@NP	the EPI-NCSCs group	16808
@NP	the distribution area and migration distance	16829
@NP	OECs and co - transplantation group .	16896
@NP	OECs and	16896
@NP	OECs	16896
@NP	transplantation group	16909
@NP	The results	16932
@NP	the area and the distance	16959
@NP	the area	16959
@NP	the distance	16972
@NP	0.497 ± 0.082 mm2 and 2.004 ± 0.479 mm	16990
@NP	0.497 ± 0.082 mm2	16990
@NP	0.497 ±	16990
@NP	0.082 mm2	16996
@NP	2.004 ± 0.479 mm	17010
@NP	2.004 ±	17010
@NP	0.479 mm	17016
@NP	the OECs group and 0.016 ± 0.012 mm2 and 0.301 ± 0.147 mm	17028
@NP	the OECs group	17028
@NP	0.016 ± 0.012 mm2 and 0.301 ± 0.147 mm	17047
@NP	0.016 ± 0.012 mm2	17047
@NP	0.016 ±	17047
@NP	0.012 mm2	17053
@NP	0.301 ± 0.147 mm	17067
@NP	0.301 ±	17067
@NP	0.147 mm	17073
@NP	the co-transplantation group	17085
@NP	The number of graft cells	17115
@NP	The number	17115
@NP	graft cells	17129
@NP	co-transplantation group than inOECs group	17153
@NP	co-transplantation group	17153
@NP	inOECs group	17183
@NP	EPI-NCSCs group	17213
@NP	3 weeks	17232
@NP	The cells count	17601
@NP	the proportion of EPI-NCSCs	17629
@NP	the proportion	17629
@NP	EPI-NCSCs	17647
@NP	37.9 ± 9.2 %	17661
@NP	37.9	17661
@NP	the others	17677
@NP	OECs -LRB- Fig. 2 -RRB-	17693
@NP	OECs	17693
@NP	Fig. 2	17699
@NP	Expression	17708
@NP	BDNF and GDNF qPCR -LRB- Fig. 3 -RRB- and immunoassaying -LRB- Fig. 4 -RRB-	17722
@NP	BDNF and GDNF qPCR	17722
@NP	Fig. 3	17742
@NP	immunoassaying	17754
@NP	Fig. 4	17770
@NP	the effects of the donor cells	17805
@NP	the effects	17805
@NP	the donor cells	17820
@NP	the expression of BDNF and GDNF	17839
@NP	the expression	17839
@NP	BDNF and GDNF	17857
@NP	molecular and protein levels in the injured cord	17874
@NP	molecular and protein levels	17874
@NP	the injured cord	17906
@NP	the co-transplanted group	17927
@NP	the expression of BDNF and GDNF at both levels	17954
@NP	the expression	17954
@NP	BDNF and GDNF	17972
@NP	both levels	17989
@NP	the control group	18040
@NP	individual cell transplantation group	18062
@NP	3 weeks posttransplantation -LRB- p < 0.05 -RRB-	18103
@NP	3 weeks posttransplantation	18103
@NP	3 weeks	18103
@NP	posttransplantation	18111
@NP	p < 0.05	18132
@NP	p	18132
@NP	< 0.05	18133
@NP	<	18133
@NP	0.05	18134
@NP	the expression of both factors in cotransplantation group	18150
@NP	the expression	18150
@NP	both factors in cotransplantation group	18168
@NP	both factors	18168
@NP	cotransplantation group	18184
@NP	9 weeks	18226
@NP	3 weeks	18248
@NP	There	18257
@NP	no statistical difference	18267
@NP	cell transplantation groups at 9 weeks posttransplantation -LRB- p > 0.05 -RRB-	18299
@NP	cell transplantation groups at 9 weeks posttransplantation	18299
@NP	cell transplantation groups	18299
@NP	9 weeks	18330
@NP	p > 0.05	18359
@NP	p	18359
@NP	> 0.05	18360
@NP	>	18360
@NP	0.05	18361
@NP	Locomotor BBB Scores All animals	18368
@NP	Locomotor BBB Scores	18368
@NP	All animals	18389
@NP	gradual improvements	18411
@NP	hind limb locomotor function	18435
@NP	the 9-week recovery period	18471
@NP	The best BBB scores	18499
@NP	The best	18499
@NP	BBB scores	18508
@NP	the OECs	18576
@NP	BBB scores for cell-injected rats	18618
@NP	BBB scores	18618
@NP	cell-injected rats	18633
@NP	significantly from the controls at p <	18661
@NP	the controls at p	18680
@NP	the controls	18680
@NP	p	18696
@NP	0.01	18698
@NP	p	18706
@NP	early and late weeks -LRB- Fig. 5 -RRB-	18717
@NP	early and late weeks	18717
@NP	Fig. 5	18739
@NP	Discussion	18749
@NP	It	18760
@NP	SCI	18784
@NP	a series	18802
@NP	pathophysiological changes	18814
@NP	apoptosis and nerve cells loss	18851
@NP	Rodriguez-Barrera	18883
@NP	et al. 2013	18901
@NP	et al.	18901
@NP	2013	18908
@NP	recent years	18918
@NP	cell transplantation for treating SCI	18932
@NP	cell transplantation	18932
@NP	SCI	18966
@NP	an interesting subject	18979
@NP	the transplanted cells	19012
@NP	microenvironment for axon regeneration	19046
@NP	microenvironment	19046
@NP	axon regeneration	19067
@NP	neurotrophic factors -LRB- NTFs -RRB-	19098
@NP	neurotrophic factors	19098
@NP	NTFs	19120
@NP	one of major mechanisms -LRB- Rich 1992 ; Zhao et al. 2004 -RRB-	19129
@NP	one	19129
@NP	major mechanisms -LRB- Rich 1992 ; Zhao et al. 2004 -RRB-	19136
@NP	major mechanisms	19136
@NP	Rich 1992 ; Zhao et al. 2004	19154
@NP	Rich 1992 ; Zhao et al.	19154
@NP	Rich 1992	19154
@NP	1992	19159
@NP	Zhao et al.	19165
@NP	Zhao	19165
@NP	et al.	19170
@NP	2004	19177
@NP	EPI-NCSCs replacement	19184
@NP	a promising strategy for SCI repair	19213
@NP	a promising strategy	19213
@NP	SCI repair	19238
@NP	the poor migration of grafted EPINCSCs in the injured cord	19259
@NP	the poor migration	19259
@NP	grafted EPINCSCs in the injured cord	19281
@NP	grafted EPINCSCs	19281
@NP	the injured cord	19301
@NP	a major challenge	19326
@NP	its use	19358
@NP	a donor cell for the repair of SCI -LRB- Sieber-Blum et al. 2006 -RRB-	19369
@NP	a donor cell	19369
@NP	the repair of SCI -LRB- Sieber-Blum et al. 2006 -RRB-	19386
@NP	the repair	19386
@NP	SCI -LRB- Sieber-Blum et al. 2006 -RRB-	19400
@NP	SCI	19400
@NP	Sieber-Blum	19405
@NP	et al. 2006	19417
@NP	et al.	19417
@NP	2006	19424
@NP	Cell migration	19431
@NP	a fundamental process during the repair of SCI	19449
@NP	a fundamental process	19449
@NP	the repair of SCI	19478
@NP	the repair	19478
@NP	SCI	19492
@NP	grafted cells	19505
@NP	sites	19543
@NP	fromthose in which they eventually reside	19561
@NP	fromthose	19561
@NP	they	19580
@NP	Liu and Rao 2003	19604
@NP	Liu	19604
@NP	Rao 2003	19612
@NP	strategies aimed at enhancing the migration of grafted EPI-NCSCs	19629
@NP	strategies	19629
@NP	the migration of grafted EPI-NCSCs	19659
@NP	the migration	19659
@NP	grafted EPI-NCSCs	19676
@NP	It	19720
@NP	OECs	19754
@NP	and secret many growth factors and chemotactic factors	19767
@NP	secret many growth factors and chemotactic factors	19771
@NP	secret many growth factors	19771
@NP	chemotactic factors	19802
@NP	GDNF , NGF , BDNF , and CNTF -LRB- Woodhall et al. 2001 ; Yin et al. 2013 -RRB-	19833
@NP	GDNF	19833
@NP	NGF , BDNF , and CNTF -LRB- Woodhall et al. 2001 ; Yin et al. 2013 -RRB-	19839
@NP	NGF , BDNF , and CNTF	19839
@NP	Woodhall	19860
@NP	et al. 2001 ; Yin et al. 2013	19869
@NP	et al. 2001 ; Yin et al.	19869
@NP	et al. 2001	19869
@NP	et al.	19869
@NP	2001	19876
@NP	Yin et al.	19882
@NP	Yin	19882
@NP	et al.	19886
@NP	2013	19893
@NP	These secreted factors	19900
@NP	These	19900
@NP	factors	19915
@NP	the growth	19943
@NP	the migration	19958
@NP	EPI-NCSCs	19975
@NP	Sadan	19986
@NP	et al. 2008 ; Cornejo et al. 2014 ; Rosenblum et al. 2014	19992
@NP	et al. 2008 ; Cornejo et al. 2014 ; Rosenblum et al.	19992
@NP	et al. 2008	19992
@NP	et al.	19992
@NP	2008	19999
@NP	Cornejo et al. 2014	20005
@NP	Cornejo	20005
@NP	et al.	20013
@NP	2014	20020
@NP	Rosenblum et al.	20026
@NP	Rosenblum	20026
@NP	et al.	20036
@NP	2014	20043
@NP	this study	20060
@NP	EPINCSCs and OECs	20072
@NP	the	20116
@NP	spinal cord	20129
@NP	1 week after injury	20144
@NP	1 week	20144
@NP	injury	20157
@NP	the ability of migration of EPI-NCSCs in vivo	20178
@NP	the ability	20178
@NP	migration of EPI-NCSCs in vivo	20193
@NP	migration	20193
@NP	EPI-NCSCs in vivo	20206
@NP	EPI-NCSCs	20206
@NP	vivo	20219
@NP	OECs	20260
@NP	The expression of BDNF and GDNF	20275
@NP	The expression	20275
@NP	BDNF and GDNF	20293
@NP	the synergism of both grafted cells	20335
@NP	the synergism	20335
@NP	both grafted cells	20352
@NP	co-transplantation of EPI-NCSCs and OECs	20385
@NP	co-transplantation	20385
@NP	EPI-NCSCs and OECs	20407
@NP	functional recovery	20435
@NP	SCI	20461
@NP	the present study	20469
@NP	it	20488
@NP	OECs	20538
@NP	the migratory distance and distribution area	20567
@NP	EPI-NCSCs in vivo , but not survival time	20615
@NP	EPI-NCSCs in vivo	20615
@NP	EPI-NCSCs	20615
@NP	vivo	20628
@NP	survival time	20642
@NP	it	20669
@NP	the migratory process	20695
@NP	various factors	20735
@NP	BDNF/GDNF	20756
@NP	a promising candidate -LRB- Mitsuhara et al. 2013 -RRB-	20776
@NP	a promising candidate	20776
@NP	Mitsuhara	20799
@NP	et al. 2013	20809
@NP	et al.	20809
@NP	2013	20816
@NP	Both factors	20823
@NP	an important role	20841
@NP	migration	20862
@NP	neural stem cells via the manner of timedependent -LRB- Hwang et al. 2009 -RRB-	20875
@NP	neural stem cells	20875
@NP	the manner of timedependent -LRB- Hwang et al. 2009 -RRB-	20897
@NP	the manner	20897
@NP	timedependent -LRB- Hwang et al. 2009 -RRB-	20911
@NP	timedependent	20911
@NP	Hwang	20926
@NP	et al. 2009	20932
@NP	et al.	20932
@NP	2009	20939
@NP	GDNF receptors	20946
@NP	the migratory pathway -LRB- Paratcha et al. 2003 -RRB-	20981
@NP	the migratory pathway	20981
@NP	Paratcha et al. 2003	21004
@NP	Paratcha	21004
@NP	et al. 2003	21013
@NP	et al.	21013
@NP	2003	21020
@NP	qPCR assay and immunohistochemical staining	21030
@NP	qPCR assay	21030
@NP	immunohistochemical staining	21045
@NP	we	21075
@NP	the expression of BDNF and GDNF at both molecular and protein levels	21089
@NP	the expression	21089
@NP	BDNF and GDNF	21107
@NP	both molecular and protein levels	21124
@NP	the cotransplantation	21175
@NP	migratory distance of EPI-NCSCs	21214
@NP	migratory distance	21214
@NP	EPI-NCSCs	21236
@NP	itself transplantation alone	21269
@NP	the mechanism of BDNF and GDNF promoting EPI-NCSCs to migrate	21309
@NP	the mechanism	21309
@NP	BDNF and GDNF	21326
@NP	EPI-NCSCs	21350
@NP	it	21372
@NP	this study	21397
@NP	It	21409
@NP	neurotrophic factors	21430
@NP	an external signal membrane surface recipient to intracellular	21464
@NP	an external signal membrane surface	21464
@NP	pseudopodia in a particular direction	21539
@NP	pseudopodia	21539
@NP	a particular direction	21554
@NP	movement -LRB- Mitsuhara et al. 2013 -RRB-	21580
@NP	movement	21580
@NP	Mitsuhara	21590
@NP	et al. 2013	21600
@NP	et al.	21600
@NP	2013	21607
@NP	the direction of the concentration gradient of NTFs	21627
@NP	the direction	21627
@NP	the concentration gradient of NTFs	21644
@NP	the concentration gradient	21644
@NP	NTFs	21674
@NP	the cell migration -LRB- Paratcha et al. 2006 -RRB-	21702
@NP	the cell migration	21702
@NP	Paratcha et al. 2006	21722
@NP	Paratcha	21722
@NP	et al. 2006	21731
@NP	et al.	21731
@NP	2006	21738
@NP	BDNF and GDNF	21745
@NP	these effects	21767
@NP	two main signaling receptors	21785
@NP	the tyrosine-kinase receptor trkB	21815
@NP	the neural cell adhesion molecule	21853
@NP	NCAM	21888
@NP	Kaplan and Miller	21895
@NP	2000 ; Paratcha and Ledda 2008	21913
@NP	2000	21913
@NP	Paratcha and Ledda 2008	21919
@NP	Paratcha	21919
@NP	Ledda 2008	21932
@NP	It	21945
@NP	NCAM	21962
@NP	these ligand -- receptor interactions -LRB- Rutishauser 2008 -RRB-	21978
@NP	these ligand	21978
@NP	receptor interactions -LRB- Rutishauser 2008 -RRB-	21991
@NP	receptor interactions	21991
@NP	Rutishauser 2008	22014
@NP	fact	22036
@NP	NCAM	22042
@NP	the interaction	22076
@NP	NTFs with trkB -LRB- Muller et al. 2000 ; Vutskits et al. 2001 -RRB-	22095
@NP	NTFs	22095
@NP	trkB -LRB- Muller et al. 2000 ; Vutskits et al. 2001 -RRB-	22105
@NP	trkB	22105
@NP	Muller	22111
@NP	et al. 2000 ; Vutskits et al. 2001	22118
@NP	et al. 2000 ; Vutskits et al.	22118
@NP	et al. 2000	22118
@NP	et al.	22118
@NP	2000	22125
@NP	Vutskits et al.	22131
@NP	Vutskits	22131
@NP	et al.	22140
@NP	2001	22147
@NP	the expression of p75 -LRB- Gascon et al. 2007 -RRB-	22169
@NP	the expression	22169
@NP	p75 -LRB- Gascon et al. 2007 -RRB-	22187
@NP	p75	22187
@NP	Gascon	22192
@NP	et al. 2007	22199
@NP	et al.	22199
@NP	2007	22206
@NP	the neuronal sensitivity	22232
@NP	the trophin	22260
@NP	NCAM	22273
@NP	NTFs	22307
@NP	the migration of enteric and rostral migratory stream neurons , respectively	22338
@NP	the migration of enteric and rostral migratory stream neurons	22338
@NP	the migration	22338
@NP	enteric and rostral migratory stream neurons	22355
@NP	Natarajan et al. 2002 ; Paratcha and Ledda 2008	22415
@NP	Natarajan	22415
@NP	et al. 2002 ; Paratcha and Ledda 2008	22425
@NP	et al. 2002	22425
@NP	et al.	22425
@NP	2002	22432
@NP	Paratcha and Ledda 2008	22438
@NP	Paratcha	22438
@NP	Ledda 2008	22451
@NP	It	22464
@NP	co-transplantation	22503
@NP	the expression of BDNF and GDNF	22530
@NP	the expression	22530
@NP	BDNF and GDNF	22548
@NP	the answer	22578
@NP	the present data	22614
@NP	it	22641
@NP	the interaction of OECs and EPI-NCSCs in the contused cord	22666
@NP	the interaction	22666
@NP	OECs and EPI-NCSCs in the contused cord	22685
@NP	OECs and EPI-NCSCs	22685
@NP	the contused cord	22707
@NP	the	22707
@NP	cord	22720
@NP	the autocrine and paracrine	22737
@NP	NTFs from the donor cells and the host neural elements , eventually	22768
@NP	NTFs from the donor cells	22768
@NP	NTFs	22768
@NP	the donor cells	22778
@NP	the host neural elements , eventually	22798
@NP	the host	22798
@NP	neural elements	22807
@NP	higher expression of BDNF and GDNF -LRB- Nicolas et al. 2014 -RRB-	22841
@NP	higher expression	22841
@NP	BDNF and GDNF -LRB- Nicolas et al. 2014 -RRB-	22862
@NP	BDNF and GDNF	22862
@NP	Nicolas	22877
@NP	et al. 2014	22885
@NP	et al.	22885
@NP	2014	22892
@NP	Previous studies	22899
@NP	OECs transplantation	22930
@NP	injured spinal cord neurons	22963
@NP	the downregulation	22995
@NP	semaphorin 3A -LRB- Sema3A -RRB- expression -LRB- Wang et al. 2011 -RRB-	23017
@NP	semaphorin 3A -LRB- Sema3A -RRB- expression	23017
@NP	semaphorin 3A -LRB- Sema3A -RRB-	23017
@NP	semaphorin 3A	23017
@NP	Sema3A	23032
@NP	Wang	23052
@NP	et al. 2011	23057
@NP	et al.	23057
@NP	2011	23064
@NP	Sema3A	23071
@NP	an axon growthmediated factor	23081
@NP	neuronal death and apoptosis	23142
@NP	inhibiting axonal regeneration	23183
@NP	spinal cord injury via plexinA3 -LRB- Ben-Zvi et al. 2008a , b -RRB-	23220
@NP	spinal cord injury	23220
@NP	plexinA3 -LRB- Ben-Zvi et al. 2008a , b -RRB-	23243
@NP	plexinA3	23243
@NP	Ben-Zvi	23253
@NP	et al. 2008a , b	23261
@NP	et al. 2008a	23261
@NP	b	23275
@NP	Sema3A	23288
@NP	the secretion of nerve growth factor	23306
@NP	the secretion	23306
@NP	nerve growth factor	23323
@NP	the modulation of the TrkA signaling pathway	23351
@NP	the modulation	23351
@NP	the TrkA signaling pathway	23369
@NP	the growth cone	23420
@NP	axonal regeneration -LRB- Ben-Zvi et al. 2008a , b -RRB-	23451
@NP	axonal regeneration	23451
@NP	Ben-Zvi	23472
@NP	et al. 2008a , b	23480
@NP	et al. 2008a	23480
@NP	b	23494
@NP	these speculation	23507
@NP	the future study	23548
@NP	the present results	23566
@NP	synergic effects of the donor cells on their migration and NTFs expression	23601
@NP	synergic effects	23601
@NP	the donor cells on their migration and NTFs expression	23621
@NP	the donor cells	23621
@NP	their migration and NTFs expression	23640
@NP	BDNF and GDNF	23689
@NP	neural regeneration	23721
@NP	tissue	23763
@NP	functional recovery -LRB- Lang et al. 2013 -RRB-	23780
@NP	functional recovery	23780
@NP	Lang	23801
@NP	et al. 2013	23806
@NP	et al.	23806
@NP	2013	23813
@NP	Both neurotrophic factors	23820
@NP	an important regulatory role	23851
@NP	neural development	23883
@NP	neuron survival	23903
@NP	axonal growth	23920
@NP	synaptic remodeling -LRB- Hawryluk et al. 2012 -RRB-	23939
@NP	synaptic remodeling	23939
@NP	Hawryluk	23960
@NP	et al. 2012	23969
@NP	et al.	23969
@NP	2012	23976
@NP	neuronal regeneration	24001
@NP	nerve cell degeneration	24036
@NP	structure and function of injured spinal cord	24083
@NP	structure and function	24083
@NP	injured spinal cord	24109
@NP	they	24130
@NP	acetylcholine and dopamine neurotransmitter release -LRB- Deng et al. 2013 -RRB-	24149
@NP	acetylcholine and dopamine neurotransmitter release	24149
@NP	Deng	24202
@NP	et al. 2013	24207
@NP	et al.	24207
@NP	2013	24214
@NP	The results of qPCR and immunohistochemistry in this study	24221
@NP	The results	24221
@NP	qPCR and immunohistochemistry in this study	24236
@NP	qPCR and immunohistochemistry	24236
@NP	this study	24269
@NP	the expression of BDNF and GDNF	24294
@NP	the expression	24294
@NP	BDNF and GDNF	24312
@NP	the highest	24330
@NP	the co-transplantation group	24345
@NP	then orderly the cellinjected and the control groups	24375
@NP	then orderly the cellinjected	24375
@NP	then orderly the	24375
@NP	the control groups	24409
@NP	their expression	24438
@NP	the co-transplantation group at 9 weeks	24473
@NP	the co-transplantation group	24473
@NP	9 weeks	24505
@NP	3 weeks may caused by the vanishing of EPINCSCs	24525
@NP	3 weeks	24525
@NP	the vanishing of EPINCSCs	24547
@NP	the vanishing	24547
@NP	EPINCSCs	24564
@NP	the co-injected animals	24574
@NP	the best performance recovery	24602
@NP	function repair	24649
@NP	the BDNF and GDNF	24685
@NP	synergic effects of EPI-NCSCs and OECs , rather than only the cell replacement	24731
@NP	synergic effects of EPI-NCSCs and OECs	24731
@NP	synergic effects	24731
@NP	EPI-NCSCs and OECs	24751
@NP	only the cell replacement	24783
@NP	cell-based therapy of SCI	24814
@NP	cell-based therapy	24814
@NP	SCI	24836
@NP	both active migration of donor cells	24841
@NP	both active migration	24841
@NP	donor cells	24866
@NP	adequate NTFs within the injured spinal cord	24882
@NP	adequate NTFs	24882
@NP	the injured spinal cord	24903
@NP	a permissive environment	24954
@NP	neural regeneration	24993
@NP	scar formation	25025
@NP	necrosis of neurons -LRB- Roloff et al. 2013 -RRB-	25054
@NP	necrosis	25054
@NP	neurons -LRB- Roloff et al. 2013 -RRB-	25066
@NP	neurons	25066
@NP	Roloff	25075
@NP	et al. 2013	25082
@NP	et al.	25082
@NP	2013	25089
@NP	The nerve degeneration and the neuron death after SCI	25096
@NP	The nerve degeneration	25096
@NP	the neuron death after SCI	25123
@NP	the neuron death	25123
@NP	SCI	25146
@NP	neurotrophic factors	25168
@NP	peripheral target tissue and injured neuron -LRB- Wrathall et al. 1998 -RRB-	25194
@NP	peripheral target tissue and injured neuron	25194
@NP	Wrathall	25239
@NP	et al. 1998	25248
@NP	et al.	25248
@NP	1998	25255
@NP	the axonal transport	25267
@NP	survival neurons	25310
@NP	neurotrophic factors	25341
@NP	NTFs	25363
@NP	neural regeneration and functional recovery	25393
@NP	neural regeneration	25393
@NP	functional recovery	25417
@NP	Fouad et al. 2013	25438
@NP	Fouad	25438
@NP	et al. 2013	25444
@NP	et al.	25444
@NP	2013	25451
@NP	exogenous and endogenous NTFs	25471
@NP	the recovery of the structure and the function of injured spinal cord	25502
@NP	the recovery	25502
@NP	the structure and the function of injured spinal cord	25518
@NP	the structure	25518
@NP	the function of injured spinal cord	25536
@NP	the function	25536
@NP	injured spinal cord	25552
@NP	Gould and Oppenheim 2004	25589
@NP	Gould	25589
@NP	Oppenheim 2004	25599
@NP	this study	25619
@NP	cell migration especially for EPI-NCSCs	25631
@NP	cell migration	25631
@NP	EPI-NCSCs	25661
@NP	higher expression	25687
@NP	BDNF and GDNF	25708
@NP	synergic effects of the co-transplantation	25734
@NP	synergic effects	25734
@NP	the co-transplantation	25754
@NP	motor function of the injured rats	25791
@NP	motor function	25791
@NP	the injured rats	25809
@NP	summary	25843
@NP	this study	25852
@NP	previous report	25873
@NP	neurotrophic factors	25894
@NP	the injured spinal cord	25943
@NP	it	25977
@NP	cotransplantation of OECs and EPI-NCSCs	26010
@NP	cotransplantation	26010
@NP	OECs and EPI-NCSCs	26031
@NP	migration of the donor cells and the expression of BDNF and GDNF	26064
@NP	migration of the donor cells	26064
@NP	migration	26064
@NP	the donor cells	26077
@NP	the expression of BDNF and GDNF	26097
@NP	the expression	26097
@NP	BDNF and GDNF	26115
@NP	locomotor recovery of the contused rats	26155
@NP	locomotor recovery	26155
@NP	the contused rats	26177
@VP	is a promising strategy for the repair of spinal cord injury -LRB- SCI -RRB-	289
@VP	are emphasized in recent years	397
@VP	emphasized in recent years	401
@VP	contused spinal cord of rats separately	556
@VP	contused cord	840
@VP	were promoted by OECs at 3 weeks after transplantation	1097
@VP	promoted by OECs at 3 weeks after transplantation	1102
@VP	vanished at 9 weeks	1162
@VP	was significantly increased by co-transplantation at molecular and protein level	1215
@VP	increased by co-transplantation at molecular and protein level	1233
@VP	was lower than in coinjected group	1375
@VP	was higher than in control groups	1414
@VP	acquired from co-injected animals	1512
@VP	know	1553
@VP	is the first time to study the synergic effects of EPI-NCSCs and OECs	1564
@VP	to study the synergic effects of EPI-NCSCs and OECs	1582
@VP	study the synergic effects of EPI-NCSCs and OECs	1585
@VP	can be improved by EPI-NCSCs and OECs synergistically	1760
@VP	be improved by EPI-NCSCs and OECs synergistically	1764
@VP	improved by EPI-NCSCs and OECs synergistically	1767
@VP	result in complete or partial loss of sensation and mobility	1907
@VP	affect the life qualities of patients	1972
@VP	reported that cell transplantation is a perspective strategy for treating SCI	2051
@VP	is a perspective strategy for treating SCI	2086
@VP	treating SCI	2116
@VP	protecting nerve cell	2237
@VP	decreasing apoptosis	2260
@VP	promoting remyelination	2282
@VP	derived from the embryonic neural crest	2790
@VP	combine the advantages of embryonic stemcells and adult stem cells	2891
@VP	remains a major challenge -LRB- Sieber-Blum et al. 2006 -RRB-	3409
@VP	induce less astrocyte response in vitro and in vivo	4149
@VP	contused spinal cord separately	4507
@VP	determining whether OECs promote EPI-NCSCs migration	4577
@VP	promote EPI-NCSCs migration	4602
@VP	were dissected from adult GFP transgenic rats	5035
@VP	dissected from adult GFP transgenic rats	5040
@VP	cleaned	5093
@VP	cut first longitudinally	5102
@VP	subsequently transversely on cavernous sinus and ring sinus	5131
@VP	rolled out of the capsule	5208
@VP	adhered to the substratum within 30 min	5292
@VP	consisted of 85 %	5357
@VP	was added	5577
@VP	added	5581
@VP	started to emigrate from the bulge explants onto the culture substratum	5612
@VP	to emigrate from the bulge explants onto the culture substratum	5620
@VP	emigrate from the bulge explants onto the culture substratum	5623
@VP	were removed	5708
@VP	removed	5713
@VP	detached by trypsin -LRB- Gibco , Grand Island , NY , USA -RRB- treatment	5744
@VP	subsequently subcultured	5809
@VP	collected and adjusted at the concentration of 1.0 × 105/ul for transplantation	6075
@VP	described previously	6240
@VP	removed from adult GFP rats	6328
@VP	dissected free of meninges and white matter	6361
@VP	minced with scalpel blades	6406
@VP	incubated for 25 min in trypsin at 37 °C within the CO2 incubator	6438
@VP	dissociated with a very gentle mechanical trituration	6521
@VP	washed	6576
@VP	collected and adjusted at the concentration of 1.0 × 105/ul for transplantation	6943
@VP	approved by TMMU Institutional Animal Care and Use Committee	7273
@VP	was performed at vertebral levels T10	7457
@VP	performed at vertebral levels T10	7461
@VP	were closed in layers	7651
@VP	closed in layers	7656
@VP	resulted in hind limb paralysis in all animals	7688
@VP	suffered hematuria and urinary retention	7753
@VP	To prevent the infections	7795
@VP	prevent the infections	7798
@VP	were randomly divided into five groups -LRB- n = 20/group -RRB-	7972
@VP	divided into five groups -LRB- n = 20/group -RRB-	7986
@VP	was the blank control without transplantation	8033
@VP	was injected of 6 ul DMEM/F12	8088
@VP	injected of 6 ul DMEM/F12	8092
@VP	was performed at day 7 after spinal cord injury	8301
@VP	performed at day 7 after spinal cord injury	8305
@VP	were anesthetized again as above	8359
@VP	was re-exposed	8417
@VP	re-exposed	8421
@VP	was used	8658
@VP	used	8662
@VP	remained in place for 5 min after each injection	8740
@VP	were injected at identical volumes of DMEM/F12 at the same sites	8810
@VP	injected at identical volumes of DMEM/F12 at the same sites	8815
@VP	were closed with interrupted sutures	8917
@VP	closed with interrupted sutures	8922
@VP	was given daily until euthanasia	8985
@VP	given daily until euthanasia	8989
@VP	fixed with 4 % paraformaldehyde and postfixed in the same fixative	9157
@VP	fixed with 4 % paraformaldehyde	9157
@VP	postfixed in the same fixative	9193
@VP	then transferred to 20 % sucrose for 48 h.	9234
@VP	were air dried at room temperature for 10 min and washed with PBS for 10 min	9537
@VP	dried at room temperature for 10 min and washed with PBS for 10 min	9546
@VP	dried at room temperature for 10 min	9546
@VP	washed with PBS for 10 min	9587
@VP	containing 0.3 % Triton X-100 for 1 h at room temperature	9674
@VP	washed in PBS three times	9963
@VP	incubated with fluorescein-conjugate affinipure -LRB- FITC -RRB-	9993
@VP	washing with PBS	10117
@VP	coverslipped with Gel / Mount aqueous mounting media	10252
@VP	mounting media	10289
@VP	were observed under fluorescence microscope -LRB- Olympus BX50 , JPN -RRB-	10318
@VP	observed under fluorescence microscope -LRB- Olympus BX50 , JPN -RRB-	10323
@VP	then montaged by Adobe Photoshop 10.0	10628
@VP	measured by Spot 345 software	10670
@VP	were designed by the GeneTool software -LRB- Biotools , USA -RRB-	10859
@VP	designed by the GeneTool software -LRB- Biotools , USA -RRB-	10864
@VP	centered on the injury site	10954
@VP	were obtained at 3 and 9 weeks after SCI -LRB- n = 5/group/time point -RRB-	10982
@VP	obtained at 3 and 9 weeks after SCI -LRB- n = 5/group/time point -RRB-	10987
@VP	Set	11427
@VP	were used	11431
@VP	used	11436
@VP	follows	11476
@VP	Melting curve analysis	11585
@VP	showed a single amplification peak for each reaction	11608
@VP	were air	11843
@VP	dried at room temperature for 10 min	11852
@VP	washed with PBS for 10 min -LRB- n = 5/group / time point -RRB-	11893
@VP	were permeabilized and blocked with 0.3 % Triton X-100 / 10 %	11958
@VP	were permeabilized	11958
@VP	blocked with 0.3 % Triton X-100 / 10 %	11981
@VP	were counterstained with hematoxylin	12550
@VP	counterstained with hematoxylin	12555
@VP	used in order to confirm the specificity of the immunohistochemical labeling	12628
@VP	to confirm the specificity of the immunohistochemical labeling	12642
@VP	confirm the specificity of the immunohistochemical labeling	12645
@VP	were observed under light microscope	12719
@VP	observed under light microscope	12724
@VP	measured with Spot 345 software	12912
@VP	compared with that of the blank control group	12948
@VP	was calculated	13068
@VP	calculated	13072
@VP	based on operationally defined behavioral features	13357
@VP	follow the recovery progression from complete paralysis to normal locomotion	13413
@VP	denotes completely normal locomotor function	13600
@VP	to move the hindlimb joints	13698
@VP	move the hindlimb joints	13701
@VP	to bear weight , and to coordinate forelimb and hindlimb movement	13727
@VP	to bear weight	13727
@VP	bear weight	13730
@VP	to coordinate forelimb and hindlimb movement	13747
@VP	coordinate forelimb and hindlimb movement	13750
@VP	are expressed as mean ± standard deviation -LRB- SD -RRB-	13825
@VP	expressed as mean ± standard deviation -LRB- SD -RRB-	13829
@VP	using one-way factorial analysis of variance -LRB- ANOVA -RRB-	13942
@VP	value < 0.05 denoted the presence of a significant difference	14000
@VP	denoted the presence of a significant difference	14012
@VP	using SPSS software version 11.0 -LRB- SPSS Inc. , Chicago , IL , USA -RRB-	14093
@VP	contused cord on the longitudinal frozen sections	14291
@VP	were higher magnification of boxed area in a	14409
@VP	c.	14454
@VP	showed GFP + graft cells	14463
@VP	indicated nuclei stained by Hoechst 33342	14494
@VP	stained by Hoechst 33342	14511
@VP	were merged pictures of GFP + and Hoechst 33342 +	14544
@VP	merged pictures of GFP + and Hoechst 33342 +	14549
@VP	point to areas of high positive expression	14905
@VP	quantified with the qPCR analysis	15051
@VP	DMEM/F12	15374
@VP	EPI-NCSCs	15393
@VP	OECs	15412
@VP	showed the survival , migration , and distribution of grafted GFP	15632
@VP	contused spinal cord -LRB- Fig. 1 -RRB-	15710
@VP	lacking migration	15862
@VP	was clear from the surrounding tissue -LRB- Fig. 1a -RRB-	15917
@VP	integrated with the host tissue , and distributed widely -LRB- Fig. 1b -RRB-	16029
@VP	integrated with the host tissue	16029
@VP	distributed widely -LRB- Fig. 1b -RRB-	16066
@VP	migrated from injection site along the longitudinal axis of the host cord	16141
@VP	crossing the injured area -LRB- Fig. 1c -RRB-	16268
@VP	could be observed in the EPI-NCSCs group	16787
@VP	be observed in the EPI-NCSCs group	16793
@VP	observed in the EPI-NCSCs group	16796
@VP	were only measured in OECs and co - transplantation group .	16874
@VP	measured in OECs and co - transplantation group .	16884
@VP	showed that the proportion of EPI-NCSCs was 37.9 ± 9.2 %	17617
@VP	was 37.9 ± 9.2 %	17657
@VP	were OECs -LRB- Fig. 2 -RRB-	17688
@VP	was attenuated at 9 weeks compared with 3 weeks	18208
@VP	attenuated at 9 weeks compared with 3 weeks	18212
@VP	treating SCI	18957
@VP	secreting neurotrophic factors -LRB- NTFs -RRB-	19088
@VP	is one of major mechanisms -LRB- Rich 1992 ; Zhao et al. 2004 -RRB-	19126
@VP	can be a promising strategy for SCI repair	19206
@VP	be a promising strategy for SCI repair	19210
@VP	differ fromthose in which they eventually reside	19554
@VP	reside	19596
@VP	aimed at enhancing the migration of grafted EPI-NCSCs	19640
@VP	enhancing the migration of grafted EPI-NCSCs	19649
@VP	should be very important	19694
@VP	be very important	19701
@VP	secreted factors	19906
@VP	was enhanced when transplanted with OECs together	20224
@VP	enhanced when transplanted with OECs together	20228
@VP	transplanted with OECs together	20242
@VP	was remarkably increased by the synergism of both grafted cells	20307
@VP	increased by the synergism of both grafted cells	20322
@VP	promoted functional recovery after SCI	20426
@VP	has been reported that the migratory process are controlled by various factors	20672
@VP	been reported that the migratory process are controlled by various factors	20676
@VP	reported that the migratory process are controlled by various factors	20681
@VP	are controlled by various factors	20717
@VP	controlled by various factors	20721
@VP	appear as a promising candidate -LRB- Mitsuhara et al. 2013 -RRB-	20766
@VP	are expressed along the migratory pathway -LRB- Paratcha et al. 2003 -RRB-	20961
@VP	expressed along the migratory pathway -LRB- Paratcha et al. 2003 -RRB-	20965
@VP	was increased by the cotransplantation	21158
@VP	increased by the cotransplantation	21162
@VP	was longer compared to itself transplantation alone	21246
@VP	Regarding the mechanism of BDNF and GDNF promoting EPI-NCSCs to migrate	21299
@VP	promoting EPI-NCSCs to migrate	21340
@VP	to migrate	21360
@VP	migrate	21363
@VP	can not be answered by this study	21375
@VP	be answered by this study	21382
@VP	answered by this study	21385
@VP	transferring an external signal membrane surface recipient to intracellular	21451
@VP	may be also related to the cell migration -LRB- Paratcha et al. 2006 -RRB-	21679
@VP	be also related to the cell migration -LRB- Paratcha et al. 2006 -RRB-	21683
@VP	also related to the cell migration -LRB- Paratcha et al. 2006 -RRB-	21686
@VP	can affect these ligand -- receptor interactions -LRB- Rutishauser 2008 -RRB-	21967
@VP	affect these ligand -- receptor interactions -LRB- Rutishauser 2008 -RRB-	21971
@VP	modulating the neuronal sensitivity to the trophin	22221
@VP	answer that how can co-transplantation promote the expression of BDNF and GDNF ?	22483
@VP	promote the expression of BDNF and GDNF	22522
@VP	could not be provided by the present data	22589
@VP	be provided by the present data	22599
@VP	provided by the present data	22602
@VP	contused cord	22711
@VP	cause higher expression of BDNF and GDNF -LRB- Nicolas et al. 2014 -RRB-	22835
@VP	has been shown to promote neuronal death and apoptosis	23116
@VP	been shown to promote neuronal death and apoptosis	23120
@VP	shown to promote neuronal death and apoptosis	23125
@VP	to promote neuronal death and apoptosis	23131
@VP	promote neuronal death and apoptosis	23134
@VP	hindering the growth cone	23410
@VP	inhibiting axonal regeneration -LRB- Ben-Zvi et al. 2008a , b -RRB-	23440
@VP	should be confirmed in the future study	23525
@VP	be confirmed in the future study	23532
@VP	confirmed in the future study	23535
@VP	was existed	23676
@VP	existed	23680
@VP	spared tissue , then for functional recovery -LRB- Lang et al. 2013 -RRB-	23756
@VP	promoting neuronal regeneration	23991
@VP	consequently improving structure and function of injured spinal cord	24060
@VP	cellinjected	24392
@VP	may caused by the vanishing of EPINCSCs	24533
@VP	caused by the vanishing of EPINCSCs	24537
@VP	suggesting that function repair can be mediated via the BDNF and GDNF	24633
@VP	can be mediated via the BDNF and GDNF	24665
@VP	be mediated via the BDNF and GDNF	24669
@VP	mediated via the BDNF and GDNF	24672
@VP	promoting neural regeneration	24983
@VP	inhibiting scar formation	25014
@VP	blocking necrosis of neurons -LRB- Roloff et al. 2013 -RRB-	25045
@VP	being interrupted	25288
@VP	competing for neurotrophic factors	25327
@VP	providing exogenous and endogenous NTFs	25461
@VP	can be improved -LRB- Gould and Oppenheim 2004 -RRB-	25572
@VP	be improved -LRB- Gould and Oppenheim 2004 -RRB-	25576
@VP	improved -LRB- Gould and Oppenheim 2004 -RRB-	25579
@VP	mediated by synergic effects of the co-transplantation	25722
@VP	was improved	25826
@VP	improved	25830
@VP	are important for repairing the injured spinal cord	25915
@VP	repairing the injured spinal cord	25933
@VP	enhance migration of the donor cells and the expression of BDNF and GDNF	26056
@VP	improve locomotor recovery of the contused rats	26147
